AMGEN INC Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Amgen Inc quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Amgen Inc Goodwill for the quarter ending September 30, 2024 was $18.7B, a 20.3% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18.7B +$3.15B +20.3% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $18.6B +$3.09B +19.9% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $18.6B +$3.04B +19.6% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $18.6B +$3.1B +20% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $15.5B +$664M +4.47% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $15.5B +$666M +4.48% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $15.5B +$634M +4.26% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $15.5B +$639M +4.29% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $14.8B +$180M +1.23% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $14.9B +$189M +1.29% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $14.9B +$224M +1.53% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $14.9B +$201M +1.37% Dec 31, 2021 10-K 2024-02-14
Q3 2021 $14.7B -$9M -0.06% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $14.7B -$2M -0.01% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $14.7B -$10M -0.07% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $14.7B -$14M -0.1% Dec 31, 2020 10-K 2023-02-09
Q3 2020 $14.7B -$31M -0.21% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $14.7B -$11M -0.08% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $14.7B -$9M -0.06% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $14.7B +$4M +0.03% Dec 31, 2019 10-K 2022-02-16
Q3 2019 $14.7B +$21M +0.14% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $14.7B -$35M -0.24% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $14.7B -$79M -0.54% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $14.7B -$62M -0.42% Dec 31, 2018 10-K 2021-02-09
Q3 2018 $14.7B -$92M -0.62% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $14.7B -$42M -0.28% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $14.8B +$14M +0.1% Mar 31, 2018 10-Q 2018-04-25
Q4 2017 $14.8B $0 0% Dec 31, 2017 10-K 2020-02-12
Q3 2017 $14.8B -$26M -0.18% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 $14.8B -$33M -0.22% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $14.8B -$47M -0.32% Mar 31, 2017 10-Q 2017-04-27
Q4 2016 $14.8B +$10M +0.07% Dec 31, 2016 10-K 2019-02-13
Q3 2016 $14.8B +$128M +0.87% Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $14.8B +$76M +0.52% Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $14.8B +$83M +0.56% Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $14.8B -$37M -0.25% Dec 31, 2015 10-K 2019-02-13
Q3 2015 $14.7B -$141M -0.95% Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $14.7B -$121M -0.82% Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $14.7B -$111M -0.75% Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $14.8B -$180M -1.2% Dec 31, 2014 10-K 2017-02-14
Q3 2014 $14.8B +$2.24B +17.8% Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $14.8B +$2.27B +18% Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $14.8B +$2.23B +17.7% Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $15B +$2.31B +18.2% Dec 31, 2013 8-K 2016-10-31
Q3 2013 $12.6B -$17M -0.14% Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $12.6B +$150M +1.21% Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $12.6B +$483M +3.99% Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $12.7B +$912M +7.76% Dec 31, 2012 10-K 2015-02-19
Q3 2012 $12.6B +$821M +6.98% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $12.4B +$634M +5.38% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $12.1B +$617M +5.36% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $11.8B +$416M +3.67% Dec 31, 2011 10-K 2014-02-24
Q3 2011 $11.8B +$434M +3.83% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $11.8B +$460M +4.06% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $11.5B +$169M +1.49% Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $11.3B Dec 31, 2010 10-K 2013-02-27
Q3 2010 $11.3B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $11.3B Jun 30, 2010 10-Q 2010-08-09
Q1 2010 $11.3B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.